- Home
- THAR vs SXTP Comparison
THAR vs SXTP Comparison
Compare THAR & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- SXTP
- Stock Information
- Founded
- THAR 2017
- SXTP 2010
- Country
- THAR United States
- SXTP United States
- Employees
- THAR N/A
- SXTP N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- SXTP Biotechnology: Pharmaceutical Preparations
- Sector
- THAR Health Care
- SXTP Health Care
- Exchange
- THAR Nasdaq
- SXTP Nasdaq
- Market Cap
- THAR 2.4M
- SXTP 2.7M
- IPO Year
- THAR 2022
- SXTP 2023
- Fundamental
- Price
- THAR $1.20
- SXTP $2.95
- Analyst Decision
- THAR Strong Buy
- SXTP Hold
- Analyst Count
- THAR 1
- SXTP 1
- Target Price
- THAR $17.00
- SXTP N/A
- AVG Volume (30 Days)
- THAR 97.3K
- SXTP 4.8M
- Earning Date
- THAR 05-08-2025
- SXTP 05-14-2025
- Dividend Yield
- THAR N/A
- SXTP N/A
- EPS Growth
- THAR N/A
- SXTP N/A
- EPS
- THAR N/A
- SXTP N/A
- Revenue
- THAR N/A
- SXTP $681,345.00
- Revenue This Year
- THAR N/A
- SXTP $95.50
- Revenue Next Year
- THAR N/A
- SXTP $80.78
- P/E Ratio
- THAR N/A
- SXTP N/A
- Revenue Growth
- THAR N/A
- SXTP 168.70
- 52 Week Low
- THAR $0.95
- SXTP $1.41
- 52 Week High
- THAR $6.45
- SXTP $36.00
- Technical
- Relative Strength Index (RSI)
- THAR 43.85
- SXTP 56.45
- Support Level
- THAR $1.05
- SXTP $2.48
- Resistance Level
- THAR $1.28
- SXTP $3.45
- Average True Range (ATR)
- THAR 0.11
- SXTP 0.70
- MACD
- THAR 0.02
- SXTP 0.02
- Stochastic Oscillator
- THAR 75.58
- SXTP 47.63
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.